0001177648-19-000003.txt : 20190213
0001177648-19-000003.hdr.sgml : 20190213
20190213205023
ACCESSION NUMBER: 0001177648-19-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190211
FILED AS OF DATE: 20190213
DATE AS OF CHANGE: 20190213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CARTER BRUCE L A
CENTRAL INDEX KEY: 0001225503
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35839
FILM NUMBER: 19600083
MAIL ADDRESS:
STREET 1: C/O ZYMOGENETICS, INC.
STREET 2: 1201 EASTLAKE AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENANTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001177648
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617 607 0800
MAIL ADDRESS:
STREET 1: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-02-11
0001177648
ENANTA PHARMACEUTICALS INC
ENTA
0001225503
CARTER BRUCE L A
C/O ENANTA PHARMACEUTICALS, INC.
500 ARSENAL STREET
WATERTOWN
MA
02472
1
0
0
0
Common Stock
2019-02-11
4
M
0
2734
23.40
A
2734
D
Common Stock
2019-02-11
4
S
0
2734
90.0153
D
0
D
Common Stock
2019-02-12
4
M
0
5000
23.40
A
5000
D
Common Stock
2019-02-12
4
S
0
5000
90.00
D
0
D
Stock Option (Right to Buy)
23.40
2019-02-11
4
M
0
2734
0
D
2023-11-22
Common Stock
2734
6546
D
Stock Option (Right to Buy)
23.40
2019-02-12
4
M
0
5000
0
D
2023-11-22
Common Stock
5000
1546
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2018.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.045, inclusive.
100% of the shares subject to the option are fully vested and exercisable.
/s/ Nathaniel S. Gardiner as attorney-in-fact
2019-02-13